Condition: Functional Mitral Regurgitation · Heart Failure · Mitral Valve Insufficiency · Sponsor: Cardiac Dimensions, Inc.
The objective of this prospective, randomized, double- blinded (patient and assessors), sham-controlled clinical trial is to assess the safety and efficacy of the CMCS in treating heart failure with functional regurgitation (FMR).
This description comes directly from the study's public registry record.
Hank Hauser · (310) 228-0016 · hhauser@cardiacdimensions.com
Always discuss trial participation with your own doctor first.
| Dignity Health Research Institute at Mercy Gilbert and Chandler Regional Medical Centers | Gilbert, Arizona, United States | Recruiting |
| Banner Health - Phoenix | Phoenix, Arizona, United States | Recruiting |
| AZ Heart Rhythm | Phoenix, Arizona, United States | Withdrawn |
| Tucson Medical Center Health | Tucson, Arizona, United States | Recruiting |
| Banner University Tuscon | Tucson, Arizona, United States | Recruiting |
| Memorial Care Hospital | Long Beach, California, United States | Terminated |
| Keck School of Medicine of USC | Los Angeles, California, United States | Recruiting |
| UCLA Medical Center | Los Angeles, California, United States | Recruiting |
| Stanford University | Redwood City, California, United States | Recruiting |
| Scripps Health | San Diego, California, United States | Recruiting |
| University of California- San Francisco | San Francisco, California, United States | Recruiting |
| South Denver Cardiology | Littleton, Colorado, United States | Recruiting |
+ 80 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03142152